- Report
- October 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- September 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- September 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- September 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- September 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- August 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- July 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- June 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- August 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- October 2025
- 90 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- October 2025
- 89 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- October 2025
- 80 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- October 2025
- 48 Pages
Global
From €1056EUR$1,200USD£913GBP
- Report
- August 2025
- 50 Pages
Global
From €8799EUR$9,995USD£7,605GBP
- Report
- July 2025
- 250 Pages
Global
From €2288EUR$2,599USD£1,978GBP
- Report
- June 2025
- 106 Pages
Global
From €3037EUR$3,450USD£2,625GBP
- Report
- June 2025
- 194 Pages
Global
From €4358EUR$4,950USD£3,766GBP
- Report
- June 2025
- 200 Pages
Europe
From €2192EUR$2,490USD£1,895GBP
- Report
- July 2025
- 54 Pages
Europe
From €2861EUR$3,250USD£2,473GBP
- Report
- July 2025
- 51 Pages
Asia Pacific
From €2861EUR$3,250USD£2,473GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more